Citadel Advisors’s Tiziana Life Sciences TLSA Stock Holding History
Bought
Maintained
Sold
Other funds holding TLSA
DIG
Citadel Advisors's TLSA Position: Q3 2026 in Review
Citadel Advisors increased its Tiziana Life Sciences (TLSA) stake by 668% in Q3 2026, buying an estimated $557K and bringing the position to 615,965 shares worth $684K. The position accounts for ﹤0.01% of the portfolio, ranked #9406.
Citadel Advisors first reported a position in TLSA in Q1 2019 and has held it in 11 quarters since. 36 funds tracked by Wall St. Rank hold TLSA as of Q3 2026.
- Citadel Advisors held 615,965 shares of Tiziana Life Sciences worth $684K as of Q3 2026.
- Citadel Advisors bought 535,743 Tiziana Life Sciences shares in Q3 2026, an estimated $557K.
- Tiziana Life Sciences made up ﹤0.01% of Citadel Advisors's portfolio in Q3 2026, its #9406 holding.
- Citadel Advisors first reported a position in Tiziana Life Sciences in Q1 2019 and has held it in 11 quarters since.
- 36 funds tracked by Wall St. Rank held Tiziana Life Sciences as of Q3 2026.
Based on Citadel Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.